Clinical Trial Update: Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing Loteprednol Ophthalmic Base and Loteprednol Ophthalmic Suspension versus placebo in an allergen challenge for allergic conjun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Loteprednol Ophthalmic Base (loteprednol etabonate)
• Loteprednol Ophthalmic Suspension (loteprednol etabonate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Allergic Conjunctivitis | Phase 2 | Status: COMPLETED | Results posted: 2012-03-21